- Home
- LBRT vs TARS Comparison
LBRT vs TARS Comparison
Compare LBRT & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRT
- TARS
- Stock Information
- Founded
- LBRT 2011
- TARS 2016
- Country
- LBRT United States
- TARS United States
- Employees
- LBRT N/A
- TARS N/A
- Industry
- LBRT Oilfield Services/Equipment
- TARS Medicinal Chemicals and Botanical Products
- Sector
- LBRT Energy
- TARS Health Care
- Exchange
- LBRT Nasdaq
- TARS Nasdaq
- Market Cap
- LBRT 1.8B
- TARS 1.7B
- IPO Year
- LBRT 2018
- TARS 2020
- Fundamental
- Price
- LBRT $10.88
- TARS $51.69
- Analyst Decision
- LBRT Hold
- TARS Strong Buy
- Analyst Count
- LBRT 9
- TARS 7
- Target Price
- LBRT $15.50
- TARS $67.14
- AVG Volume (30 Days)
- LBRT 3.5M
- TARS 679.4K
- Earning Date
- LBRT 10-15-2025
- TARS 11-12-2025
- Dividend Yield
- LBRT 2.86%
- TARS N/A
- EPS Growth
- LBRT N/A
- TARS N/A
- EPS
- LBRT 1.30
- TARS N/A
- Revenue
- LBRT $4,102,134,000.00
- TARS $295,521,000.00
- Revenue This Year
- LBRT N/A
- TARS $33,170.29
- Revenue Next Year
- LBRT N/A
- TARS N/A
- P/E Ratio
- LBRT $8.60
- TARS N/A
- Revenue Growth
- LBRT N/A
- TARS 254.45
- 52 Week Low
- LBRT $9.50
- TARS $30.23
- 52 Week High
- LBRT $23.58
- TARS $59.76
- Technical
- Relative Strength Index (RSI)
- LBRT 48.30
- TARS 46.25
- Support Level
- LBRT $10.68
- TARS $48.20
- Resistance Level
- LBRT $11.46
- TARS $59.76
- Average True Range (ATR)
- LBRT 0.56
- TARS 2.04
- MACD
- LBRT 0.07
- TARS -1.29
- Stochastic Oscillator
- LBRT 62.82
- TARS 30.19
About LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.